4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-21-082070
Options or other derivatives
- Chief Financial Officer acquired 37,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bellemin Jean-Marc · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-14 | Grant or award : show line 1 in the form Restricted Stock Units | +37,700 | 37,700 | D |
Loading xslF345X03/tm2119923-4_4seq1.xml…